Why does chemotherapy stop affecting the cells of ovarian and breast tumors?

Future Oncol. 2018 May;14(12):1137-1140. doi: 10.2217/fon-2018-0001. Epub 2018 Apr 9.
No abstract available

Keywords: cisplatin; doxorubicin; multidrug resistance of cancer cells; redox homeostasis, ovarian and breast cancer cells; thioredoxins, peroxiredoxins and thioredoxin reductases.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology
  • Cisplatin / pharmacology
  • Cisplatin / therapeutic use
  • Doxorubicin / pharmacology
  • Doxorubicin / therapeutic use
  • Drug Resistance, Multiple / genetics*
  • Drug Resistance, Neoplasm / genetics*
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / pathology
  • Oxidation-Reduction
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Doxorubicin
  • Cisplatin